Intangible outcomes from a policy change: Using contingent valuation to quantify potential stigma from a cannabis offence

Journal of Experimental Criminology

Volumn 10, Issue 1, 2014, Pages 59-77

  Shanahan, Marian ^a   Ritter, Alison ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cannabis; Cannabis policy; Contingent valuation; Economic evaluation; Stigma

Indexed keywords

EID: 84897647240     PISSN: 15733750     EISSN: 15728315     Source Type: Journal    
DOI: 10.1007/s11292-013-9176-1     Document Type: Article

References (70)

1. Ableson, P. (2000). Public economics principles and practice. Sydney: Applied Economics.
2. ACT Government Health Directorate. (2011). ACT Drug Diversion Data Activity Report 2010-2011. Canberra: ACT Health.
3. Ahern, J., Stuber, J., & Galea, S. (2007). Stigma, discrimination and the health of illicit drug users. Drug and Alcohol Dependence, 88, 188-196.
4. Arrow, K., Solow, R., et al. (1993). Report of the NOAA Panel on Contingent Valuation.
5. Atkinson, G., Healley, A., & Mourato, S. (2005). Valuing the cost of violent crime: a stated preference approach. Oxford Economic Papers, 57, 559-585.
6. Australian Bureau of Statistics. (2006). NSW 2006 census data. Canberra: Australian Bureau of Statistics.
7. Australian Bureau of Statistics. (2010). 6202. 0 - Labour force, Australia. Canberra: Commonwealth Government of Australia.
8. Australian Institute of Health and Welfare. (2008). 2007 National drug strategy household survey. First results drug statistics series No 20. Canberra: Australian Institute of Health and Welfare.
9. Baker, J., & Goh, D. (2004). The cannabis cautioning scheme three years on: An implementation and outcome evaluation. Sydney: Bureau of Crime Statistics and Research.
10. Bartels, R., Fiebig, D., & va Soest, A. (2006). Consumers and experts: an econometric analysis of the demand for water heaters. Empirical Economics, 31, 369-391.
11. Boardman, A., Greenbery, D., Vining, A., & Weimer, D. (2001). Cost-benefit analysis: Concepts and practice (2nd ed.). Upper Saddle River: Prentice Hall.
12. Borghi, J. (2007). Aggregation rules for cost-benefit analysis: a health economics perspective. Health Economics, 17, 863-875.
13. Bureau of Crime Statistics and Research. (2006). Court statistics. Sydney: NSW Government Law Link.
14. Champ, P. and Welsh, M. (2006). Survey methodologies for stated choice studies. Valuing Environmental Amenities Stated Choice Methods. A Common Sense Approach to Theory and Practice. Dordrecht: Springer.
15. Chilton, S., Covey, J., Jones-Lee, M., Loomes, G., & Metcalf, H. (2004). Valuation of health benefits associated with reductions in air pollution. Final report. London: Department for Environment, Food and Rural Affairs.
16. Cohen, M. (2007). Valuing crime control benefits using stated preferences approaches. Nashville: Vanderbilt University.
17. Cohen, M., Rust, R., Steen, S., & Tidd, S. (2004). Willingness-to-pay for crime control programs. Criminology, 42(1), 89-109.
18. Crime Research Centre (2007). WA Diversion Program - Evaluation Framework (POP/STIR/IDP) Final Report for the Drug and Alcohol Office. Perth University of Western Australia.
19. Crocker, J., Major, B., & Steele, C. (1998). Social stigma. In D. Gilbert, S. T. Fiske, & G. Lindsey (Eds.), The handbook of social psychology (pp. 504-553). New York: McGraw-Hill.
20. Diener, A., O'Brien, B., & Gafni, A. (1998). Health care contingent valuation studies: a review and classification of the literature. Health Economics, 7, 313-326.
21. Dolan, P., & Peasgood, T. (2007). Estimating the economic and social costs of the fear of crime. British Journal of Criminololgy, 47(1), 121-132.
22. Dolan, P., Loomes, G., Peasgood, T., & Tsuchiya, A. (2005). Estimating the intangible victim costs of violent crime. British Journal of Criminololgy, 45(6), 958-976.
23. Douglas, B. and McDonald, D. (2012.). The prohibition of illicit drugs is killing and criminalising our children and we are all letting it happen, Australia 21. http://www. australia21. org. au//publications/press_releases/Australia21_Illicit_Drug_Policy_Report. pdf.
24. Frew, E. (2010). Benefit assessment for cost-benefit analysis studies in health care using contingent valuation methods. In E. McIntosh, P. Clarke, E. Frew, & J. Louviere (Eds.), Applied methods of cost-benefit analysis in health care. Oxford: Oxford University Press.
25. Funk, P. (2004). On the elective use of stigma as a crime-deterrent. European Economic Review, 48, 715-728.
26. Furuya, K. (2002). A socio-economic model of stigma and related social problems. Journal of Economic Behavior & Organization, 48, 281-290.
27. Gettman, J. (2007). Lost taxes and other consequences of marijuana laws. The Bulletin of Cannabis Reform., 4.
28. Global Commission on Drugs Policy. (2011). War on drugs. Ipanema, Brazil: Global Commission on Drugs Policy.
29. Golafshani, N. (2003). Understanding reliablity and validity in qualitative research. The Qualitative Report, 8, 597-607.
30. Haden, M. (2008). Controlling illegal stimulants: a regulated market model. Harm Reduction Journal, 5, 1477-7517.
31. Hathaway, A., Comeau, N., & Erickson, P. (2011). Cannabis normalization and stigma: contemporary practices of moral regulation. Criminology & Criminal Justice, 11(5), 451-469.
32. Hughes, C. and Ritter, A. (2008). A summary of diversion programs for drug and drug-related offenders in Australia. DPMP Monographs. Sydney, National Drug and Alcohol Research Centre. No. 16.
33. Hughes, C., & Stevens, A. (2007). The effects of decriminalization of drug Use in Portugal. The Beckley Foundation Drug Policy Programme Briefing Paper, 14.
34. Hunter, N. (2001). Cannabis expiation notice (CENs) in South Australia, 1997 to 2000. Information Bulletin. Adelaide, Office of Crime Statistics, Attorney General's Department. No 27.
35. Jacoby, A. (1994). "Felt versus enacted stigma: a concept revisited." Social Science and Medicine(38): 269-274.
36. Johannesson, M., Jonsson, B., & Karlsson, G. (1996). Outcome measurement in economic evaluation. Health Economics, 5, 279-296.
37. Lenton, S. (2005). Deterrence theory and the limitations of criminal penalties for cannabis use. In T. Stockwell, P. Gruenewald, J. Toumbourou, & W. Loxley (Eds.), Preventing harmful substance Use. West Sussex: John Wiley and Sons.
38. Lenton, S., & Heale, P. (2000). Arrest, court and social impacts of conviction for a minor cannabis offence under strict prohibition. Contemporary Drug Problems, 27, 807-832.
39. Lenton, S., Christie, P., et al. (1999). Infringement versus conviction: the social impact of a minor cannabis offence under a civil penalties system and strict prohibition in Two Australian states. Canberra: Commonwealth Department of Health and Aged Care.
40. Lloyd, L. (2010). Sinning and Sinned Against: The Stigmatisation of Problem Drug Users. London: University of York.
41. Lopes, G., Krohn, M., Lizotte, A. D., Schmidt, N. M., Vásquez, B. E., & Bernburg, J. G. (2012). Labeling and cumulative disadvantage: The impact of formal police intervention on life chances and crime during emerging adulthood. Crime & Delinquency, 58, 456-488.
42. Lott, J. (1992). An attempt at measuring the total monetary penalty from drug convictions: The importance of an individual's reputation. The Journal of Legal Studies, 21, 159-187.
43. Louviere, J., & Lancsar, E. (2009). Choice experiments in health: the good, the bad, the ugly and toward a brighter future. Health Economics, Policy, and Law, 4, 527-546.
44. Ludgwig, J., & Cook, P. (2001). The benefits of reducing gun violence: Evidence from contingent-valuation survey data. Journal of Risk and Uncertainty, 22, 207-226.
45. McKeganey, N. (2010) "Bad stigma... Good Stigma?" Drink and Drug News.
46. McKnight, D. (2005). Beyond right and left new politics and the culture wars. Sydeny: Allen & Unwin.
47. OECD Project on Income Distribution and Poverty. (2005). "What are equivalence scales?" Retrieved May 15, 2010, from http://www. oecd. org/dataoecd/61/52/35411111. pdf.
48. Olsen, S. (2009). Choosing between internet and mail survey modes for choice experiment surveys considering Non-market goods. Environmental Resource Economics, 44, 591-610.
49. Olsen, J., & Smith, R. (2001). Theory vesus practice: a review of willingness-to-pay in health and health care. Health Economics, 10, 39-52.
50. Pager, D. (2003). The mark of a criminal record. The American Journal of Sociology, 108, 937-975.
51. Pearce, D., Atkinson, G. and Mourato, S. (2006). Cost benefit analysis and the environment. Recent developments. OECD.
52. Pellegrini, S. and Jeanrenaud, C. (2003) Willingness to pay of the Swiss population for a public health programme against alcohol dependence. Neuchatel: University of Neuchatel.
53. Phillips, T., Tranter, B., Mitchell, D., Clark, J., & Reed, K. (2007). Australian survey of social attitudes, 2007. Canberra: The Australian National University, ACSPRI Centre for Social Research.
54. Piquero, N., Cohen, M., & Piquero, A. (2011). How much is the public willing to Pay to be protected from identity theft? Justice Quarterly, 28, 437-459.
55. Rasmusen, E. (1996). Stigma and self-fulfilling expectations of criminality. Journal of Law and Economics, 39, 519-544.
56. Room, R., Fischer, B., Hall, W., Lenton, S. and Reuter, P. (2008). Cannabis Policy: Moving beyond stalemate. Global Cannabis Commission Foundation Oxford: Beckley Foundation.
57. Schwarzinger, M., Carrat, G., & Luchini, S. (2009). "If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question" evidence from a double-bounded dichotomous choice model with heterogeneous anchoring. Journal of Health Economics, 29, 873-884.
58. Smith, R. (2000). The discrete-choice willingness-to-pay question format in health economics. Medical Decision Making, 20, 194-206.
59. Smith, R. (2003). Construction of the contingent valuation market in health care: A critical assessment. Health Economics, 12, 609-628.
60. Smith, R. (2006). It's not just what you do, it's the way that you do it: The effect of different payment card formats and survey administration on willingness to pay for health gain. Health Economics, 15, 281-293.
61. Smith, R. (2007). Use, option and externality values: Are contingent valuation studies in health care mis-specified? Health Economics, 16, 861-869.
62. UNODC (2010). World Drug Report 2010, United Nations Publication Sales No. E. 10. XI. 13: 194.
63. van Dijk, J. (1998). The narrow margins of the Dutch drug policy: A cost benefit analysis. European Journal on Criminal Policy and Research, 6, 369-393.
64. van Laar, M. and van Ooyen-Houben, M. (2009). Evaluation Dutch Drug Policy, Trimbos instituut, Netherlands Institute of Mental Health and Addiction.
65. Vining, A., & Weimer, D. (2010). An assessment of important issues concerning the application of benefit-cost analysis to social policy. Journal of Benefit-Cost Analyisis, 1(1), 1-37.
66. Weatherburn, D., & Jones, C. (2001). Does prohibition deter cannabis use? crime and justice bulletin. Sydney: Bureau of Crime Statistics and Research, New South Wales Attorney's General Department.
67. Weatherburn, D., Jones, C., & Donnelly, N. (2003). Prohibition and Cannabis Use in Australia: A Survey of 18- to 29-year-olds. Australian and New Zealand Journal of Criminology, 36(1), 77-93.
68. Willis, K., Powe, N., & Garrod, G. (2005). Estimating the value of improved street lighting: A factor analytical discrete choice approach. Urban Studies, 42(12), 2289-2303.
69. Wodak, A., Reinarman, C., & Cohen, P. (2002). Cannabis control: costs outweigh the benefits: For. British Medical Journal, 324, 105-106.
70. Wooldridge, J. (2009). Introductory econometrics. A modern approach. Mason: South-Western Cengage Learning.